RE:RE:RE:RE:Of all analysts DOWNGRADES, Raymond James got it rightHatrikSeLaine wrote: Does anyone have any indication as to how many shares have been eliminated as a result of the NCIB to date?
Hatrik, this is what I know to be factual. Publicly traded companies are required to report on a quarterly basis any and all shares repurchased under a current NCIB program, so the answer is zero.
Depending on what is going on in the healthcare space and internally within the company, one has to ask yourself if the NCIB is the best way to create shareholder value. It worked for Viemed, but that was way back, times were different and their business model is different than Quipt's.
Admittedly I am not the sharpest tool in the shed when it comes to all this business stuff, but if you just look at the rotech deal, Qipt's current SP makes no sense at all. As mentioned before Quipt now finds itself in a unique position of being ranked 4th largest company in the space.
They probably do get taken out at some point, but once again until some other company steps up to the plate with an offer, it's pure speculation in my view. What was the rotech deal, 6.3 times I believe? Raymond James is out to lunch with their report, and they know it, it's garbage throw it in the trash. I have no clue what their motives are and I don't care.
Listen, everyone on this board including me has an opinion right. The key is doing your own research and finding out as much as possible what the facts are. At least that way you should be able to make an informed descesion as to selling your shares, or continuing to hold.